Deals

Derma Sciences Closes $75M CMPO near Market via Piper Jaffray, Canaccord Genuity

By |

Derma Sciences, Inc. (DSCI) announced that it has raised $74,999,999 in a CMPO/Overnight transaction. The common stock was sold at $11.50 per share, an approximate 4% discount to the market price ($12.00) of DSCI at deal announcement. Piper Jaffray and Canaccord Genuity acted as Joint Book-Running Managers with Oppenheimer and Roth Capital Partners as Financial Advisors on the transaction. Underwriter counsel was Goodwin Procter and issuer counsel was Thompson & Hine. The transaction is expected to close on January 29, 2014.

Deals

Atossa Genetics Closes $14M CMPO via Dawson James

By |

Atossa Genetics Inc. (ATOS) announced that it has raised $13,920,000 in a CMPO/Overnight transaction. The common stock was sold at $2.40 per share, an approximate 25% discount to the market price ($3.20) of ATOS at deal announcement. A series of 1,160,000 60-Month Warrants with an exercise price of $3.00 per share (6.25% discount) was issued to the investors in this transaction. Dawson James Securities, Inc. acted as the Sole Book-Runner on the transaction. Underwriter counsel was Ellenoff Grossman & Schole LLP and issuer counsel was Ropes & Gray.

Deals

Tonix Pharmaceuticals Closes $43.5M CMPO at 9% Discount via Roth Capital, National Securities Corp.

By |

Tonix Pharmaceuticals Holding Corporation (TNXP) announced that it has raised $43,478,250 in a CMPO/Overnight transaction. The common stock was sold at $15.00 per share, an approximate 9% discount to the market price ($16.40) of TNXP at deal announcement. Roth Capital Partners, LLC acted as Sole Book-Running Manager and National Securities Corporation acted as Co-Manager on the transaction. Underwriter counsel was Lowenstein Sandler, PC and issuer counsel was Sichenzia Ross Friedman Ference, LLP. Note this Placement is subject to customary closing conditions and is expected to close by 01/29/2014.

Deals

Exelixis Closes $80M CMPO at Market via Cowen

By |

Exelixis, Inc. (EXEL) announced that it has raised $80,000,000 in a CMPO/Overnight transaction. The common stock was sold at $8.00 per share, an approximate 1% discount to the market price ($8.07) of EXEL at deal announcement. Cowen and Company acted as Underwriter on the transaction. Underwriter counsel was Sullivan & Cromwell and issuer counsel was Cooley. The transaction is expected to close on January 28, 2014.